APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Mealtime Insulin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Mealtime Insulin Industry Growth and Trends Forecast to 2032

Report ID 174010430128 December 2025115 pages

Choose your research edition.

Industry ResearchMealtime Insulin Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Mealtime Insulin Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Mealtime Insulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mealtime Insulin Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Mealtime Insulin Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Mealtime Insulin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Mealtime Insulin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Mealtime Insulin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mealtime Insulin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mealtime Insulin include Abbott Laboratories, BASF, Biocon Biologics, Gan & Lee Pharmaceuticals, Novo Nordisk, Wockhardt, Bayer, HTBT and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Mealtime Insulin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Mealtime Insulin market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mealtime Insulin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mealtime Insulin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Mealtime Insulin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Mealtime Insulin Market by Company

Abbott Laboratories

BASF

Biocon Biologics

Gan & Lee Pharmaceuticals

Novo Nordisk

Wockhardt

Bayer

HTBT

Pfizer

Sinovac Biotech

Eli Lilly

Sanofi

Tonghua Dongbao Pharmaceutical

Wanbang Biopharmaceuticals

Zhuhai United Pharmaceutical

Mealtime Insulin Segment by Type

Rapid-acting Insulin Analogs

Short-acting Insulin

Mealtime Insulin Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Mealtime Insulin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mealtime Insulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mealtime Insulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mealtime Insulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mealtime Insulin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Mealtime Insulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Rapid-acting Insulin Analogs Table 2. Major Company of Short-acting Insulin Table 3. Global Mealtime Insulin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Mealtime Insulin Sales by Type (2021-2026) & (K Units) Table 5. Global Mealtime Insulin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Mealtime Insulin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Mealtime Insulin Sales Market Share in Value by Type (2021-2026) Table 8. Global Mealtime Insulin Price by Type (2021-2026) & (US$/Unit) Table 9. Global Mealtime Insulin Sales by Type (2027-2032) & (K Units) Table 10. Global Mealtime Insulin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Mealtime Insulin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Mealtime Insulin Sales Market Share in Value by Type (2027-2032) Table 13. Global Mealtime Insulin Price by Type (2027-2032) & (US$/Unit) Table 14. North America Mealtime Insulin Sales by Type (2021-2026) & (K Units) Table 15. North America Mealtime Insulin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Mealtime Insulin Sales by Type (2021-2026) & (K Units) Table 17. Europe Mealtime Insulin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Mealtime Insulin Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Mealtime Insulin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Mealtime Insulin Sales by Type (2021-2026) & (K Units) Table 21. Latin America Mealtime Insulin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Mealtime Insulin Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Mealtime Insulin Sales by Type (2021-2026) & (US$ Million) Table 24. Mealtime Insulin Industry Trends Table 25. Mealtime Insulin Industry Drivers Table 26. Mealtime Insulin Industry Opportunities and Challenges Table 27. Mealtime Insulin Industry Restraints Table 28. Global Mealtime Insulin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Mealtime Insulin Revenue Market Share by Company (2021-2026) Table 30. Global Mealtime Insulin Sales by Company (2021-2026) & (K Units) Table 31. Global Mealtime Insulin Sales Share by Company (2021-2026) Table 32. Global Mealtime Insulin Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Mealtime Insulin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Mealtime Insulin Major Company Production Sites and Headquarters Table 35. Global Mealtime Insulin Company, Product Type & Application Table 36. Global Mealtime Insulin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Mealtime Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Mealtime Insulin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Mealtime Insulin Sales by Region (2021-2026) & (K Units) Table 41. Global Mealtime Insulin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Mealtime Insulin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Mealtime Insulin Sales Market Share in Value by Region (2021-2026) Table 44. Global Mealtime Insulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Mealtime Insulin Sales by Region (2027-2032) & (K Units) Table 46. Global Mealtime Insulin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Mealtime Insulin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Mealtime Insulin Sales Market Share in Value by Region (2027-2032) Table 49. Global Mealtime Insulin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Mealtime Insulin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Mealtime Insulin Sales by Application (2021-2026) & (K Units) Table 52. Global Mealtime Insulin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Mealtime Insulin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Mealtime Insulin Sales Market Share in Value by Application (2021-2026) Table 55. Global Mealtime Insulin Price by Application (2021-2026) & (US$/Unit) Table 56. Global Mealtime Insulin Sales by Application (2027-2032) & (K Units) Table 57. Global Mealtime Insulin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Mealtime Insulin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Mealtime Insulin Sales Market Share in Value by Application (2027-2032) Table 60. Global Mealtime Insulin Price by Application (2027-2032) & (US$/Unit) Table 61. North America Mealtime Insulin Sales by Application (2021-2026) & (K Units) Table 62. North America Mealtime Insulin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Mealtime Insulin Sales by Application (2021-2026) & (K Units) Table 64. Europe Mealtime Insulin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Mealtime Insulin Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Mealtime Insulin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Mealtime Insulin Sales by Application (2021-2026) & (K Units) Table 68. Latin America Mealtime Insulin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Mealtime Insulin Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Mealtime Insulin Sales by Application (2021-2026) & (US$ Million) Table 71. Abbott Laboratories Company Information Table 72. Abbott Laboratories Business Overview Table 73. Abbott Laboratories Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Abbott Laboratories Mealtime Insulin Product Portfolio Table 75. Abbott Laboratories Recent Development Table 76. BASF Company Information Table 77. BASF Business Overview Table 78. BASF Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. BASF Mealtime Insulin Product Portfolio Table 80. BASF Recent Development Table 81. Biocon Biologics Company Information Table 82. Biocon Biologics Business Overview Table 83. Biocon Biologics Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Biocon Biologics Mealtime Insulin Product Portfolio Table 85. Biocon Biologics Recent Development Table 86. Gan & Lee Pharmaceuticals Company Information Table 87. Gan & Lee Pharmaceuticals Business Overview Table 88. Gan & Lee Pharmaceuticals Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Gan & Lee Pharmaceuticals Mealtime Insulin Product Portfolio Table 90. Gan & Lee Pharmaceuticals Recent Development Table 91. Novo Nordisk Company Information Table 92. Novo Nordisk Business Overview Table 93. Novo Nordisk Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Novo Nordisk Mealtime Insulin Product Portfolio Table 95. Novo Nordisk Recent Development Table 96. Wockhardt Company Information Table 97. Wockhardt Business Overview Table 98. Wockhardt Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Wockhardt Mealtime Insulin Product Portfolio Table 100. Wockhardt Recent Development Table 101. Bayer Company Information Table 102. Bayer Business Overview Table 103. Bayer Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Bayer Mealtime Insulin Product Portfolio Table 105. Bayer Recent Development Table 106. HTBT Company Information Table 107. HTBT Business Overview Table 108. HTBT Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. HTBT Mealtime Insulin Product Portfolio Table 110. HTBT Recent Development Table 111. Pfizer Company Information Table 112. Pfizer Business Overview Table 113. Pfizer Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Pfizer Mealtime Insulin Product Portfolio Table 115. Pfizer Recent Development Table 116. Sinovac Biotech Company Information Table 117. Sinovac Biotech Business Overview Table 118. Sinovac Biotech Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Sinovac Biotech Mealtime Insulin Product Portfolio Table 120. Sinovac Biotech Recent Development Table 121. Eli Lilly Company Information Table 122. Eli Lilly Business Overview Table 123. Eli Lilly Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Eli Lilly Mealtime Insulin Product Portfolio Table 125. Eli Lilly Recent Development Table 126. Sanofi Company Information Table 127. Sanofi Business Overview Table 128. Sanofi Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Sanofi Mealtime Insulin Product Portfolio Table 130. Sanofi Recent Development Table 131. Tonghua Dongbao Pharmaceutical Company Information Table 132. Tonghua Dongbao Pharmaceutical Business Overview Table 133. Tonghua Dongbao Pharmaceutical Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Tonghua Dongbao Pharmaceutical Mealtime Insulin Product Portfolio Table 135. Tonghua Dongbao Pharmaceutical Recent Development Table 136. Wanbang Biopharmaceuticals Company Information Table 137. Wanbang Biopharmaceuticals Business Overview Table 138. Wanbang Biopharmaceuticals Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Wanbang Biopharmaceuticals Mealtime Insulin Product Portfolio Table 140. Wanbang Biopharmaceuticals Recent Development Table 141. Zhuhai United Pharmaceutical Company Information Table 142. Zhuhai United Pharmaceutical Business Overview Table 143. Zhuhai United Pharmaceutical Mealtime Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Zhuhai United Pharmaceutical Mealtime Insulin Product Portfolio Table 145. Zhuhai United Pharmaceutical Recent Development Table 146. North America Mealtime Insulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. North America Mealtime Insulin Sales by Country (2021-2026) & (K Units) Table 148. North America Mealtime Insulin Sales Market Share by Country (2021-2026) Table 149. North America Mealtime Insulin Sales Forecast by Country (2027-2032) & (K Units) Table 150. North America Mealtime Insulin Sales Market Share Forecast by Country (2027-2032) Table 151. North America Mealtime Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. North America Mealtime Insulin Market Size by Country (2021-2026) & (US$ Million) Table 153. North America Mealtime Insulin Market Share by Country (2021-2026) Table 154. North America Mealtime Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. North America Mealtime Insulin Market Share Forecast by Country (2027-2032) Table 156. Europe Mealtime Insulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Europe Mealtime Insulin Sales by Country (2021-2026) & (K Units) Table 158. Europe Mealtime Insulin Sales Market Share by Country (2021-2026) Table 159. Europe Mealtime Insulin Sales Forecast by Country (2027-2032) & (K Units) Table 160. Europe Mealtime Insulin Sales Market Share Forecast by Country (2027-2032) Table 161. Europe Mealtime Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Europe Mealtime Insulin Market Size by Country (2021-2026) & (US$ Million) Table 163. Europe Mealtime Insulin Market Share by Country (2021-2026) Table 164. Europe Mealtime Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Europe Mealtime Insulin Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Mealtime Insulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Mealtime Insulin Sales by Country (2021-2026) & (K Units) Table 168. Asia-Pacific Mealtime Insulin Sales Market Share by Country (2021-2026) Table 169. Asia-Pacific Mealtime Insulin Sales Forecast by Country (2027-2032) & (K Units) Table 170. Asia-Pacific Mealtime Insulin Sales Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Mealtime Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Mealtime Insulin Market Size by Country (2021-2026) & (US$ Million) Table 173. Asia-Pacific Mealtime Insulin Market Share by Country (2021-2026) Table 174. Asia-Pacific Mealtime Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Asia-Pacific Mealtime Insulin Market Share Forecast by Country (2027-2032) Table 176. Latin America Mealtime Insulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Latin America Mealtime Insulin Sales by Country (2021-2026) & (K Units) Table 178. Latin America Mealtime Insulin Sales Market Share by Country (2021-2026) Table 179. Latin America Mealtime Insulin Sales Forecast by Country (2027-2032) & (K Units) Table 180. Latin America Mealtime Insulin Sales Market Share Forecast by Country (2027-2032) Table 181. Latin America Mealtime Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Latin America Mealtime Insulin Market Size by Country (2021-2026) & (US$ Million) Table 183. Latin America Mealtime Insulin Market Share by Country (2021-2026) Table 184. Latin America Mealtime Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Latin America Mealtime Insulin Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Mealtime Insulin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Mealtime Insulin Sales by Country (2021-2026) & (K Units) Table 188. Middle East and Africa Mealtime Insulin Sales Market Share by Country (2021-2026) Table 189. Middle East and Africa Mealtime Insulin Sales Forecast by Country (2027-2032) & (K Units) Table 190. Middle East and Africa Mealtime Insulin Sales Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Mealtime Insulin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Mealtime Insulin Market Size by Country (2021-2026) & (US$ Million) Table 193. Middle East and Africa Mealtime Insulin Market Share by Country (2021-2026) Table 194. Middle East and Africa Mealtime Insulin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Middle East and Africa Mealtime Insulin Market Share Forecast by Country (2027-2032) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Mealtime Insulin Distributors List Table 199. Mealtime Insulin Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Mealtime Insulin Image Figure 2. Global Mealtime Insulin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mealtime Insulin Market Size (2021-2032) & (US$ Million) Figure 4. Global Mealtime Insulin Sales (2021-2032) & (K Units) Figure 5. Rapid-acting Insulin Analogs Image Figure 6. Global Rapid-acting Insulin Analogs Sales YoY Growth (2021-2032) & (K Units) Figure 7. Short-acting Insulin Image Figure 8. Global Short-acting Insulin Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Mealtime Insulin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Mealtime Insulin Market Share by Type 2025 VS 2032 Figure 11. North America Mealtime Insulin Sales Market Share in Volume by Type in 2025 Figure 12. North America Mealtime Insulin Sales Market Share in Value by Type in 2025 Figure 13. Europe Mealtime Insulin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Mealtime Insulin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Mealtime Insulin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Mealtime Insulin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Mealtime Insulin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Mealtime Insulin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Mealtime Insulin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Mealtime Insulin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Mealtime Insulin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital and Clinic Image Figure 24. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 25. Retail Pharmacies Image Figure 26. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Mealtime Insulin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Mealtime Insulin Market Share by Application 2025 VS 2032 Figure 31. North America Mealtime Insulin Sales Market Share in Volume by Application in 2025 Figure 32. North America Mealtime Insulin Sales Market Share in Value by Application in 2025 Figure 33. Europe Mealtime Insulin Sales Market Share in Volume by Application in 2025 Figure 34. Europe Mealtime Insulin Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Mealtime Insulin Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Mealtime Insulin Sales Market Share in Value by Application in 2025 Figure 37. Latin America Mealtime Insulin Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Mealtime Insulin Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Mealtime Insulin Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Mealtime Insulin Sales Market Share in Value by Application in 2025 Figure 41. North America Mealtime Insulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Mealtime Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Mealtime Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Mealtime Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Mealtime Insulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Mealtime Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Mealtime Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Mealtime Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Mealtime Insulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Mealtime Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Mealtime Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Mealtime Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Mealtime Insulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Mealtime Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Mealtime Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Mealtime Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Mealtime Insulin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Mealtime Insulin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Mealtime Insulin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Mealtime Insulin Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Mealtime Insulin Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Mealtime Insulin Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Rapid-acting Insulin Analogs
  • Short-acting Insulin
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Abbott Laboratories
  • BASF
  • Biocon Biologics
  • Gan & Lee Pharmaceuticals
  • Novo Nordisk
  • Wockhardt
  • Bayer
  • HTBT
  • Pfizer
  • Sinovac Biotech
  • Eli Lilly
  • Sanofi
  • Tonghua Dongbao Pharmaceutical
  • Wanbang Biopharmaceuticals
  • Zhuhai United Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mealtime Insulin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Mealtime Insulin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Mealtime Insulin Market by Type
  6. 1.3.1 Rapid-acting Insulin Analogs
  7. 1.3.2 Short-acting Insulin
  8. 1.4 Global Mealtime Insulin Market Size by Type
  9. 1.4.1 Global Mealtime Insulin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Mealtime Insulin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Mealtime Insulin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Mealtime Insulin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Mealtime Insulin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Mealtime Insulin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Mealtime Insulin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Mealtime Insulin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Mealtime Insulin Industry Trends
  2. 2.2 Mealtime Insulin Industry Drivers
  3. 2.3 Mealtime Insulin Industry Opportunities and Challenges
  4. 2.4 Mealtime Insulin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Mealtime Insulin Revenue (2021-2026)
  2. 3.2 Global Top Players by Mealtime Insulin Sales (2021-2026)
  3. 3.3 Global Top Players by Mealtime Insulin Price (2021-2026)
  4. 3.4 Global Mealtime Insulin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mealtime Insulin Major Company Production Sites & Headquarters
  6. 3.6 Global Mealtime Insulin Company, Product Type & Application
  7. 3.7 Global Mealtime Insulin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mealtime Insulin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mealtime Insulin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mealtime Insulin Tier 1, Tier 2, and Tier 3
4 Mealtime Insulin Regional Status and Outlook
  1. 4.1 Global Mealtime Insulin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Mealtime Insulin Historic Market Size by Region
  3. 4.2.1 Global Mealtime Insulin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Mealtime Insulin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Mealtime Insulin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Mealtime Insulin Forecasted Market Size by Region
  7. 4.3.1 Global Mealtime Insulin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Mealtime Insulin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Mealtime Insulin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Mealtime Insulin by Application
  1. 5.1 Mealtime Insulin Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Mealtime Insulin Market Size by Application
  6. 5.2.1 Global Mealtime Insulin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Mealtime Insulin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Mealtime Insulin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Mealtime Insulin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Mealtime Insulin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Mealtime Insulin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Mealtime Insulin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Mealtime Insulin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott Laboratories
  2. 6.1.1 Abbott Laboratories Company Information
  3. 6.1.2 Abbott Laboratories Business Overview
  4. 6.1.3 Abbott Laboratories Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Laboratories Mealtime Insulin Product Portfolio
  6. 6.1.5 Abbott Laboratories Recent Developments
  7. 6.2 BASF
  8. 6.2.1 BASF Company Information
  9. 6.2.2 BASF Business Overview
  10. 6.2.3 BASF Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 BASF Mealtime Insulin Product Portfolio
  12. 6.2.5 BASF Recent Developments
  13. 6.3 Biocon Biologics
  14. 6.3.1 Biocon Biologics Company Information
  15. 6.3.2 Biocon Biologics Business Overview
  16. 6.3.3 Biocon Biologics Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Biocon Biologics Mealtime Insulin Product Portfolio
  18. 6.3.5 Biocon Biologics Recent Developments
  19. 6.4 Gan & Lee Pharmaceuticals
  20. 6.4.1 Gan & Lee Pharmaceuticals Company Information
  21. 6.4.2 Gan & Lee Pharmaceuticals Business Overview
  22. 6.4.3 Gan & Lee Pharmaceuticals Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Gan & Lee Pharmaceuticals Mealtime Insulin Product Portfolio
  24. 6.4.5 Gan & Lee Pharmaceuticals Recent Developments
  25. 6.5 Novo Nordisk
  26. 6.5.1 Novo Nordisk Company Information
  27. 6.5.2 Novo Nordisk Business Overview
  28. 6.5.3 Novo Nordisk Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novo Nordisk Mealtime Insulin Product Portfolio
  30. 6.5.5 Novo Nordisk Recent Developments
  31. 6.6 Wockhardt
  32. 6.6.1 Wockhardt Company Information
  33. 6.6.2 Wockhardt Business Overview
  34. 6.6.3 Wockhardt Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Wockhardt Mealtime Insulin Product Portfolio
  36. 6.6.5 Wockhardt Recent Developments
  37. 6.7 Bayer
  38. 6.7.1 Bayer Company Information
  39. 6.7.2 Bayer Business Overview
  40. 6.7.3 Bayer Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bayer Mealtime Insulin Product Portfolio
  42. 6.7.5 Bayer Recent Developments
  43. 6.8 HTBT
  44. 6.8.1 HTBT Company Information
  45. 6.8.2 HTBT Business Overview
  46. 6.8.3 HTBT Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 HTBT Mealtime Insulin Product Portfolio
  48. 6.8.5 HTBT Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Pfizer Mealtime Insulin Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 Sinovac Biotech
  56. 6.10.1 Sinovac Biotech Company Information
  57. 6.10.2 Sinovac Biotech Business Overview
  58. 6.10.3 Sinovac Biotech Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sinovac Biotech Mealtime Insulin Product Portfolio
  60. 6.10.5 Sinovac Biotech Recent Developments
  61. 6.11 Eli Lilly
  62. 6.11.1 Eli Lilly Company Information
  63. 6.11.2 Eli Lilly Business Overview
  64. 6.11.3 Eli Lilly Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Eli Lilly Mealtime Insulin Product Portfolio
  66. 6.11.5 Eli Lilly Recent Developments
  67. 6.12 Sanofi
  68. 6.12.1 Sanofi Company Information
  69. 6.12.2 Sanofi Business Overview
  70. 6.12.3 Sanofi Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Sanofi Mealtime Insulin Product Portfolio
  72. 6.12.5 Sanofi Recent Developments
  73. 6.13 Tonghua Dongbao Pharmaceutical
  74. 6.13.1 Tonghua Dongbao Pharmaceutical Company Information
  75. 6.13.2 Tonghua Dongbao Pharmaceutical Business Overview
  76. 6.13.3 Tonghua Dongbao Pharmaceutical Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Tonghua Dongbao Pharmaceutical Mealtime Insulin Product Portfolio
  78. 6.13.5 Tonghua Dongbao Pharmaceutical Recent Developments
  79. 6.14 Wanbang Biopharmaceuticals
  80. 6.14.1 Wanbang Biopharmaceuticals Company Information
  81. 6.14.2 Wanbang Biopharmaceuticals Business Overview
  82. 6.14.3 Wanbang Biopharmaceuticals Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Wanbang Biopharmaceuticals Mealtime Insulin Product Portfolio
  84. 6.14.5 Wanbang Biopharmaceuticals Recent Developments
  85. 6.15 Zhuhai United Pharmaceutical
  86. 6.15.1 Zhuhai United Pharmaceutical Company Information
  87. 6.15.2 Zhuhai United Pharmaceutical Business Overview
  88. 6.15.3 Zhuhai United Pharmaceutical Mealtime Insulin Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Zhuhai United Pharmaceutical Mealtime Insulin Product Portfolio
  90. 6.15.5 Zhuhai United Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Mealtime Insulin Sales by Country
  2. 7.1.1 North America Mealtime Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Mealtime Insulin Sales by Country (2021-2026)
  4. 7.1.3 North America Mealtime Insulin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Mealtime Insulin Market Size by Country
  6. 7.2.1 North America Mealtime Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Mealtime Insulin Market Size by Country (2021-2026)
  8. 7.2.3 North America Mealtime Insulin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Mealtime Insulin Sales by Country
  2. 8.1.1 Europe Mealtime Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Mealtime Insulin Sales by Country (2021-2026)
  4. 8.1.3 Europe Mealtime Insulin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Mealtime Insulin Market Size by Country
  6. 8.2.1 Europe Mealtime Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Mealtime Insulin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Mealtime Insulin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Mealtime Insulin Sales by Country
  2. 9.1.1 Asia-Pacific Mealtime Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Mealtime Insulin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Mealtime Insulin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Mealtime Insulin Market Size by Country
  6. 9.2.1 Asia-Pacific Mealtime Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Mealtime Insulin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Mealtime Insulin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Mealtime Insulin Sales by Country
  2. 10.1.1 South America Mealtime Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Mealtime Insulin Sales by Country (2021-2026)
  4. 10.1.3 South America Mealtime Insulin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Mealtime Insulin Market Size by Country
  6. 10.2.1 South America Mealtime Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Mealtime Insulin Market Size by Country (2021-2026)
  8. 10.2.3 South America Mealtime Insulin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Mealtime Insulin Sales by Country
  2. 11.1.1 Middle East and Africa Mealtime Insulin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Mealtime Insulin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Mealtime Insulin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Mealtime Insulin Market Size by Country
  6. 11.2.1 Middle East and Africa Mealtime Insulin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Mealtime Insulin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Mealtime Insulin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Mealtime Insulin Value Chain Analysis
  2. 12.1.1 Mealtime Insulin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Mealtime Insulin Production Mode & Process
  7. 12.2 Mealtime Insulin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Mealtime Insulin Distributors
  10. 12.2.3 Mealtime Insulin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst